nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—Methotrexate—muscle cancer	0.451	1	CrCtD
Leucovorin—Folic Acid—Methotrexate—muscle cancer	0.0597	0.2	CrCrCtD
Leucovorin—Pralatrexate—Methotrexate—muscle cancer	0.0597	0.2	CrCrCtD
Leucovorin—Pemetrexed—Methotrexate—muscle cancer	0.0597	0.2	CrCrCtD
Leucovorin—Raltitrexed—Methotrexate—muscle cancer	0.0597	0.2	CrCrCtD
Leucovorin—Tetrahydrofolic acid—Methotrexate—muscle cancer	0.0597	0.2	CrCrCtD
Leucovorin—TYMS—Methotrexate—muscle cancer	0.0435	0.188	CbGbCtD
Leucovorin—ABCC3—Vincristine—muscle cancer	0.0373	0.161	CbGbCtD
Leucovorin—ABCC3—Etoposide—muscle cancer	0.0342	0.148	CbGbCtD
Leucovorin—ABCC3—Doxorubicin—muscle cancer	0.0233	0.101	CbGbCtD
Leucovorin—ABCC3—Methotrexate—muscle cancer	0.0226	0.0976	CbGbCtD
Leucovorin—ABCC4—Methotrexate—muscle cancer	0.0172	0.0745	CbGbCtD
Leucovorin—ABCC2—Vincristine—muscle cancer	0.0169	0.0732	CbGbCtD
Leucovorin—ABCC2—Etoposide—muscle cancer	0.0155	0.0671	CbGbCtD
Leucovorin—ABCC2—Doxorubicin—muscle cancer	0.0106	0.0458	CbGbCtD
Leucovorin—ABCC2—Methotrexate—muscle cancer	0.0103	0.0443	CbGbCtD
Leucovorin—Caecitis—Doxorubicin—muscle cancer	0.00101	0.054	CcSEcCtD
Leucovorin—Febrile neutropenia—Dactinomycin—muscle cancer	0.000561	0.03	CcSEcCtD
Leucovorin—Febrile neutropenia—Vincristine—muscle cancer	0.000501	0.0268	CcSEcCtD
Leucovorin—TYMS—Vinorelbine—Vincristine—muscle cancer	0.000436	0.372	CbGdCrCtD
Leucovorin—TYMS—Podofilox—Etoposide—muscle cancer	0.000436	0.372	CbGdCrCtD
Leucovorin—Febrile neutropenia—Etoposide—muscle cancer	0.000406	0.0217	CcSEcCtD
Leucovorin—Extravasation—Dactinomycin—muscle cancer	0.000387	0.0207	CcSEcCtD
Leucovorin—Sensitisation—Doxorubicin—muscle cancer	0.000355	0.019	CcSEcCtD
Leucovorin—Extravasation—Vincristine—muscle cancer	0.000346	0.0185	CcSEcCtD
Leucovorin—TYMS—Vinblastine—Vincristine—muscle cancer	0.0003	0.256	CbGdCrCtD
Leucovorin—Rigors—Etoposide—muscle cancer	0.000299	0.016	CcSEcCtD
Leucovorin—Neuropathy—Vincristine—muscle cancer	0.000283	0.0151	CcSEcCtD
Leucovorin—Extravasation—Etoposide—muscle cancer	0.00028	0.015	CcSEcCtD
Leucovorin—Kidney function abnormal—Doxorubicin—muscle cancer	0.000262	0.014	CcSEcCtD
Leucovorin—Lethargy—Dactinomycin—muscle cancer	0.00025	0.0134	CcSEcCtD
Leucovorin—Febrile neutropenia—Methotrexate—muscle cancer	0.000243	0.013	CcSEcCtD
Leucovorin—Neuropathy—Etoposide—muscle cancer	0.000229	0.0123	CcSEcCtD
Leucovorin—Febrile neutropenia—Doxorubicin—muscle cancer	0.000211	0.0113	CcSEcCtD
Leucovorin—Serum creatinine increased—Doxorubicin—muscle cancer	0.000206	0.011	CcSEcCtD
Leucovorin—Stomatitis—Dactinomycin—muscle cancer	0.000184	0.00984	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Etoposide—muscle cancer	0.000183	0.0098	CcSEcCtD
Leucovorin—Extravasation—Methotrexate—muscle cancer	0.000168	0.00897	CcSEcCtD
Leucovorin—Neuropathy peripheral—Vincristine—muscle cancer	0.000165	0.00884	CcSEcCtD
Leucovorin—Stomatitis—Vincristine—muscle cancer	0.000164	0.00879	CcSEcCtD
Leucovorin—Rigors—Doxorubicin—muscle cancer	0.000155	0.0083	CcSEcCtD
Leucovorin—Chills—Dactinomycin—muscle cancer	0.000152	0.00813	CcSEcCtD
Leucovorin—Alopecia—Dactinomycin—muscle cancer	0.00015	0.00801	CcSEcCtD
Leucovorin—Erythema—Dactinomycin—muscle cancer	0.000148	0.00789	CcSEcCtD
Leucovorin—Extravasation—Doxorubicin—muscle cancer	0.000145	0.00776	CcSEcCtD
Leucovorin—Ill-defined disorder—Dactinomycin—muscle cancer	0.000137	0.00732	CcSEcCtD
Leucovorin—Neuropathy peripheral—Etoposide—muscle cancer	0.000134	0.00716	CcSEcCtD
Leucovorin—Alopecia—Vincristine—muscle cancer	0.000134	0.00716	CcSEcCtD
Leucovorin—Stomatitis—Etoposide—muscle cancer	0.000133	0.00712	CcSEcCtD
Leucovorin—Malaise—Dactinomycin—muscle cancer	0.000133	0.00711	CcSEcCtD
Leucovorin—Leukopenia—Dactinomycin—muscle cancer	0.000132	0.00706	CcSEcCtD
Leucovorin—Discomfort—Dactinomycin—muscle cancer	0.000124	0.00664	CcSEcCtD
Leucovorin—Infection—Dactinomycin—muscle cancer	0.00012	0.0064	CcSEcCtD
Leucovorin—Neuropathy—Doxorubicin—muscle cancer	0.000119	0.00636	CcSEcCtD
Leucovorin—Leukopenia—Vincristine—muscle cancer	0.000118	0.00631	CcSEcCtD
Leucovorin—Thrombocytopenia—Dactinomycin—muscle cancer	0.000118	0.0063	CcSEcCtD
Leucovorin—Renal failure acute—Methotrexate—muscle cancer	0.000115	0.00615	CcSEcCtD
Leucovorin—Anorexia—Dactinomycin—muscle cancer	0.000115	0.00614	CcSEcCtD
Leucovorin—Convulsion—Vincristine—muscle cancer	0.000114	0.00611	CcSEcCtD
Leucovorin—Chills—Etoposide—muscle cancer	0.00011	0.00589	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00011	0.00587	CcSEcCtD
Leucovorin—Alopecia—Etoposide—muscle cancer	0.000108	0.0058	CcSEcCtD
Leucovorin—Lethargy—Methotrexate—muscle cancer	0.000108	0.0058	CcSEcCtD
Leucovorin—Anaphylactic shock—Vincristine—muscle cancer	0.000108	0.00575	CcSEcCtD
Leucovorin—Infection—Vincristine—muscle cancer	0.000107	0.00571	CcSEcCtD
Leucovorin—Thrombocytopenia—Vincristine—muscle cancer	0.000105	0.00563	CcSEcCtD
Leucovorin—Decreased appetite—Dactinomycin—muscle cancer	0.000105	0.0056	CcSEcCtD
Leucovorin—Dysgeusia—Etoposide—muscle cancer	0.000105	0.00559	CcSEcCtD
Leucovorin—Fatigue—Dactinomycin—muscle cancer	0.000104	0.00555	CcSEcCtD
Leucovorin—Anorexia—Vincristine—muscle cancer	0.000103	0.00548	CcSEcCtD
Leucovorin—Renal failure acute—Doxorubicin—muscle cancer	9.96e-05	0.00533	CcSEcCtD
Leucovorin—Feeling abnormal—Dactinomycin—muscle cancer	9.92e-05	0.00531	CcSEcCtD
Leucovorin—Ill-defined disorder—Etoposide—muscle cancer	9.91e-05	0.0053	CcSEcCtD
Leucovorin—Gastrointestinal pain—Dactinomycin—muscle cancer	9.85e-05	0.00526	CcSEcCtD
Leucovorin—Renal impairment—Doxorubicin—muscle cancer	9.66e-05	0.00517	CcSEcCtD
Leucovorin—Malaise—Etoposide—muscle cancer	9.63e-05	0.00515	CcSEcCtD
Leucovorin—Leukopenia—Etoposide—muscle cancer	9.56e-05	0.00511	CcSEcCtD
Leucovorin—Body temperature increased—Dactinomycin—muscle cancer	9.52e-05	0.00509	CcSEcCtD
Leucovorin—Abdominal pain—Dactinomycin—muscle cancer	9.52e-05	0.00509	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Doxorubicin—muscle cancer	9.5e-05	0.00508	CcSEcCtD
Leucovorin—Loss of consciousness—Etoposide—muscle cancer	9.39e-05	0.00502	CcSEcCtD
Leucovorin—Lethargy—Doxorubicin—muscle cancer	9.39e-05	0.00502	CcSEcCtD
Leucovorin—Decreased appetite—Vincristine—muscle cancer	9.35e-05	0.005	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Vincristine—muscle cancer	9.29e-05	0.00497	CcSEcCtD
Leucovorin—Fatigue—Vincristine—muscle cancer	9.28e-05	0.00496	CcSEcCtD
Leucovorin—Convulsion—Etoposide—muscle cancer	9.25e-05	0.00495	CcSEcCtD
Leucovorin—Constipation—Vincristine—muscle cancer	9.2e-05	0.00492	CcSEcCtD
Leucovorin—Discomfort—Etoposide—muscle cancer	8.98e-05	0.0048	CcSEcCtD
Leucovorin—Hypersensitivity—Dactinomycin—muscle cancer	8.87e-05	0.00474	CcSEcCtD
Leucovorin—Gastrointestinal pain—Vincristine—muscle cancer	8.8e-05	0.0047	CcSEcCtD
Leucovorin—Confusional state—Etoposide—muscle cancer	8.79e-05	0.0047	CcSEcCtD
Leucovorin—Anaphylactic shock—Etoposide—muscle cancer	8.72e-05	0.00466	CcSEcCtD
Leucovorin—Infection—Etoposide—muscle cancer	8.66e-05	0.00463	CcSEcCtD
Leucovorin—Asthenia—Dactinomycin—muscle cancer	8.64e-05	0.00462	CcSEcCtD
Leucovorin—Blood creatinine increased—Doxorubicin—muscle cancer	8.62e-05	0.00461	CcSEcCtD
Leucovorin—Thrombocytopenia—Etoposide—muscle cancer	8.53e-05	0.00456	CcSEcCtD
Leucovorin—Abdominal pain—Vincristine—muscle cancer	8.5e-05	0.00455	CcSEcCtD
Leucovorin—Body temperature increased—Vincristine—muscle cancer	8.5e-05	0.00455	CcSEcCtD
Leucovorin—Skin disorder—Etoposide—muscle cancer	8.47e-05	0.00453	CcSEcCtD
Leucovorin—Abdominal pain upper—Doxorubicin—muscle cancer	8.4e-05	0.00449	CcSEcCtD
Leucovorin—Anorexia—Etoposide—muscle cancer	8.31e-05	0.00444	CcSEcCtD
Leucovorin—Diarrhoea—Dactinomycin—muscle cancer	8.24e-05	0.00441	CcSEcCtD
Leucovorin—Stomatitis—Methotrexate—muscle cancer	7.98e-05	0.00427	CcSEcCtD
Leucovorin—Hypersensitivity—Vincristine—muscle cancer	7.93e-05	0.00424	CcSEcCtD
Leucovorin—Dyspnoea—Etoposide—muscle cancer	7.77e-05	0.00415	CcSEcCtD
Leucovorin—Asthenia—Vincristine—muscle cancer	7.72e-05	0.00413	CcSEcCtD
Leucovorin—Vomiting—Dactinomycin—muscle cancer	7.66e-05	0.00409	CcSEcCtD
Leucovorin—Rash—Dactinomycin—muscle cancer	7.59e-05	0.00406	CcSEcCtD
Leucovorin—Decreased appetite—Etoposide—muscle cancer	7.58e-05	0.00405	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Etoposide—muscle cancer	7.52e-05	0.00402	CcSEcCtD
Leucovorin—Fatigue—Etoposide—muscle cancer	7.51e-05	0.00402	CcSEcCtD
Leucovorin—Constipation—Etoposide—muscle cancer	7.45e-05	0.00398	CcSEcCtD
Leucovorin—Diarrhoea—Vincristine—muscle cancer	7.36e-05	0.00394	CcSEcCtD
Leucovorin—Feeling abnormal—Etoposide—muscle cancer	7.18e-05	0.00384	CcSEcCtD
Leucovorin—Nausea—Dactinomycin—muscle cancer	7.15e-05	0.00382	CcSEcCtD
Leucovorin—Gastrointestinal pain—Etoposide—muscle cancer	7.13e-05	0.00381	CcSEcCtD
Leucovorin—Dizziness—Vincristine—muscle cancer	7.11e-05	0.0038	CcSEcCtD
Leucovorin—Neuropathy peripheral—Doxorubicin—muscle cancer	6.95e-05	0.00371	CcSEcCtD
Leucovorin—Urticaria—Etoposide—muscle cancer	6.92e-05	0.0037	CcSEcCtD
Leucovorin—Stomatitis—Doxorubicin—muscle cancer	6.91e-05	0.00369	CcSEcCtD
Leucovorin—Body temperature increased—Etoposide—muscle cancer	6.89e-05	0.00368	CcSEcCtD
Leucovorin—Abdominal pain—Etoposide—muscle cancer	6.89e-05	0.00368	CcSEcCtD
Leucovorin—Vomiting—Vincristine—muscle cancer	6.84e-05	0.00366	CcSEcCtD
Leucovorin—Rash—Vincristine—muscle cancer	6.78e-05	0.00363	CcSEcCtD
Leucovorin—Dermatitis—Vincristine—muscle cancer	6.78e-05	0.00362	CcSEcCtD
Leucovorin—Chills—Methotrexate—muscle cancer	6.59e-05	0.00353	CcSEcCtD
Leucovorin—Alopecia—Methotrexate—muscle cancer	6.49e-05	0.00347	CcSEcCtD
Leucovorin—Hypersensitivity—Etoposide—muscle cancer	6.42e-05	0.00343	CcSEcCtD
Leucovorin—Erythema—Methotrexate—muscle cancer	6.4e-05	0.00342	CcSEcCtD
Leucovorin—Nausea—Vincristine—muscle cancer	6.39e-05	0.00342	CcSEcCtD
Leucovorin—Dysgeusia—Methotrexate—muscle cancer	6.26e-05	0.00335	CcSEcCtD
Leucovorin—Asthenia—Etoposide—muscle cancer	6.25e-05	0.00334	CcSEcCtD
Leucovorin—Pruritus—Etoposide—muscle cancer	6.17e-05	0.0033	CcSEcCtD
Leucovorin—Diarrhoea—Etoposide—muscle cancer	5.96e-05	0.00319	CcSEcCtD
Leucovorin—Ill-defined disorder—Methotrexate—muscle cancer	5.93e-05	0.00317	CcSEcCtD
Leucovorin—Malaise—Methotrexate—muscle cancer	5.77e-05	0.00308	CcSEcCtD
Leucovorin—Dizziness—Etoposide—muscle cancer	5.76e-05	0.00308	CcSEcCtD
Leucovorin—Leukopenia—Methotrexate—muscle cancer	5.73e-05	0.00306	CcSEcCtD
Leucovorin—Chills—Doxorubicin—muscle cancer	5.71e-05	0.00305	CcSEcCtD
Leucovorin—Alopecia—Doxorubicin—muscle cancer	5.62e-05	0.00301	CcSEcCtD
Leucovorin—Convulsion—Methotrexate—muscle cancer	5.54e-05	0.00296	CcSEcCtD
Leucovorin—Vomiting—Etoposide—muscle cancer	5.54e-05	0.00296	CcSEcCtD
Leucovorin—Erythema—Doxorubicin—muscle cancer	5.54e-05	0.00296	CcSEcCtD
Leucovorin—Rash—Etoposide—muscle cancer	5.49e-05	0.00294	CcSEcCtD
Leucovorin—Dermatitis—Etoposide—muscle cancer	5.49e-05	0.00294	CcSEcCtD
Leucovorin—Dysgeusia—Doxorubicin—muscle cancer	5.42e-05	0.0029	CcSEcCtD
Leucovorin—Discomfort—Methotrexate—muscle cancer	5.38e-05	0.00288	CcSEcCtD
Leucovorin—Confusional state—Methotrexate—muscle cancer	5.26e-05	0.00281	CcSEcCtD
Leucovorin—Anaphylactic shock—Methotrexate—muscle cancer	5.22e-05	0.00279	CcSEcCtD
Leucovorin—Infection—Methotrexate—muscle cancer	5.19e-05	0.00277	CcSEcCtD
Leucovorin—Nausea—Etoposide—muscle cancer	5.18e-05	0.00277	CcSEcCtD
Leucovorin—Ill-defined disorder—Doxorubicin—muscle cancer	5.14e-05	0.00275	CcSEcCtD
Leucovorin—Thrombocytopenia—Methotrexate—muscle cancer	5.11e-05	0.00273	CcSEcCtD
Leucovorin—Skin disorder—Methotrexate—muscle cancer	5.07e-05	0.00271	CcSEcCtD
Leucovorin—Malaise—Doxorubicin—muscle cancer	4.99e-05	0.00267	CcSEcCtD
Leucovorin—Anorexia—Methotrexate—muscle cancer	4.98e-05	0.00266	CcSEcCtD
Leucovorin—Syncope—Doxorubicin—muscle cancer	4.97e-05	0.00266	CcSEcCtD
Leucovorin—Leukopenia—Doxorubicin—muscle cancer	4.96e-05	0.00265	CcSEcCtD
Leucovorin—Loss of consciousness—Doxorubicin—muscle cancer	4.87e-05	0.0026	CcSEcCtD
Leucovorin—Convulsion—Doxorubicin—muscle cancer	4.8e-05	0.00257	CcSEcCtD
Leucovorin—Discomfort—Doxorubicin—muscle cancer	4.66e-05	0.00249	CcSEcCtD
Leucovorin—Dyspnoea—Methotrexate—muscle cancer	4.65e-05	0.00249	CcSEcCtD
Leucovorin—Dyspepsia—Methotrexate—muscle cancer	4.6e-05	0.00246	CcSEcCtD
Leucovorin—Confusional state—Doxorubicin—muscle cancer	4.56e-05	0.00244	CcSEcCtD
Leucovorin—Decreased appetite—Methotrexate—muscle cancer	4.54e-05	0.00243	CcSEcCtD
Leucovorin—Anaphylactic shock—Doxorubicin—muscle cancer	4.52e-05	0.00242	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Methotrexate—muscle cancer	4.51e-05	0.00241	CcSEcCtD
Leucovorin—Fatigue—Methotrexate—muscle cancer	4.5e-05	0.00241	CcSEcCtD
Leucovorin—Infection—Doxorubicin—muscle cancer	4.49e-05	0.0024	CcSEcCtD
Leucovorin—Shock—Doxorubicin—muscle cancer	4.45e-05	0.00238	CcSEcCtD
Leucovorin—Thrombocytopenia—Doxorubicin—muscle cancer	4.43e-05	0.00237	CcSEcCtD
Leucovorin—Skin disorder—Doxorubicin—muscle cancer	4.39e-05	0.00235	CcSEcCtD
Leucovorin—Anorexia—Doxorubicin—muscle cancer	4.31e-05	0.0023	CcSEcCtD
Leucovorin—Feeling abnormal—Methotrexate—muscle cancer	4.3e-05	0.0023	CcSEcCtD
Leucovorin—Gastrointestinal pain—Methotrexate—muscle cancer	4.27e-05	0.00228	CcSEcCtD
Leucovorin—Urticaria—Methotrexate—muscle cancer	4.15e-05	0.00222	CcSEcCtD
Leucovorin—Abdominal pain—Methotrexate—muscle cancer	4.13e-05	0.00221	CcSEcCtD
Leucovorin—Body temperature increased—Methotrexate—muscle cancer	4.13e-05	0.00221	CcSEcCtD
Leucovorin—Dyspnoea—Doxorubicin—muscle cancer	4.03e-05	0.00215	CcSEcCtD
Leucovorin—Dyspepsia—Doxorubicin—muscle cancer	3.98e-05	0.00213	CcSEcCtD
Leucovorin—Decreased appetite—Doxorubicin—muscle cancer	3.93e-05	0.0021	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Doxorubicin—muscle cancer	3.9e-05	0.00209	CcSEcCtD
Leucovorin—Fatigue—Doxorubicin—muscle cancer	3.9e-05	0.00208	CcSEcCtD
Leucovorin—Constipation—Doxorubicin—muscle cancer	3.87e-05	0.00207	CcSEcCtD
Leucovorin—Hypersensitivity—Methotrexate—muscle cancer	3.85e-05	0.00206	CcSEcCtD
Leucovorin—Asthenia—Methotrexate—muscle cancer	3.75e-05	0.002	CcSEcCtD
Leucovorin—Feeling abnormal—Doxorubicin—muscle cancer	3.72e-05	0.00199	CcSEcCtD
Leucovorin—Gastrointestinal pain—Doxorubicin—muscle cancer	3.7e-05	0.00198	CcSEcCtD
Leucovorin—Pruritus—Methotrexate—muscle cancer	3.69e-05	0.00197	CcSEcCtD
Leucovorin—Urticaria—Doxorubicin—muscle cancer	3.59e-05	0.00192	CcSEcCtD
Leucovorin—Abdominal pain—Doxorubicin—muscle cancer	3.57e-05	0.00191	CcSEcCtD
Leucovorin—Body temperature increased—Doxorubicin—muscle cancer	3.57e-05	0.00191	CcSEcCtD
Leucovorin—Diarrhoea—Methotrexate—muscle cancer	3.57e-05	0.00191	CcSEcCtD
Leucovorin—Dizziness—Methotrexate—muscle cancer	3.45e-05	0.00185	CcSEcCtD
Leucovorin—Hypersensitivity—Doxorubicin—muscle cancer	3.33e-05	0.00178	CcSEcCtD
Leucovorin—Vomiting—Methotrexate—muscle cancer	3.32e-05	0.00177	CcSEcCtD
Leucovorin—Rash—Methotrexate—muscle cancer	3.29e-05	0.00176	CcSEcCtD
Leucovorin—Dermatitis—Methotrexate—muscle cancer	3.29e-05	0.00176	CcSEcCtD
Leucovorin—Asthenia—Doxorubicin—muscle cancer	3.24e-05	0.00173	CcSEcCtD
Leucovorin—Pruritus—Doxorubicin—muscle cancer	3.2e-05	0.00171	CcSEcCtD
Leucovorin—Nausea—Methotrexate—muscle cancer	3.1e-05	0.00166	CcSEcCtD
Leucovorin—Diarrhoea—Doxorubicin—muscle cancer	3.09e-05	0.00165	CcSEcCtD
Leucovorin—Dizziness—Doxorubicin—muscle cancer	2.99e-05	0.0016	CcSEcCtD
Leucovorin—Vomiting—Doxorubicin—muscle cancer	2.87e-05	0.00154	CcSEcCtD
Leucovorin—Rash—Doxorubicin—muscle cancer	2.85e-05	0.00152	CcSEcCtD
Leucovorin—Dermatitis—Doxorubicin—muscle cancer	2.85e-05	0.00152	CcSEcCtD
Leucovorin—Nausea—Doxorubicin—muscle cancer	2.68e-05	0.00144	CcSEcCtD
